Caixin App
Newsletter
Weekly Magazine
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Commentary & Analysis
Weekend Long Read
Video
ESG
Topics
China Goes Global
Asia New Vision Forum 2025
Asia New Vision Forum 2024
Selected
CX Daily
Weekly Must-Read
Caixin Briefs
Economic Indexes
Caixin Explains
News Graphics
ThinkChina
The Wall Street Journal
Podcast
Highlights
Newsletter
Events
Impact
Asia Central Banking
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
zhou xinda
China Opens New Insurance Path for High-Cost Drugs
Cover Story: Chinese Medicine Injections Face Rigorous Regulation for the First Time
In Depth: Byzantine Billing System Holds Back Chinese Hospitals’ Embrace of Private Insurance
Low Interest Rates Squeeze China’s Retirement Dreams, Survey Shows
China Provinces Scrap Hukou Limits for Medical Insurance to Boost Mobility
China Targets Drug Over-Prescribing to Curb Insurance Fraud
China Tops World in Chronic Kidney Disease Cases, Study Shows
China Reaches ’Lower-Moderate’ TB Incidence for First Time
China Eases Drug Procurement Rules, Keeps Winning Bids Secret
China’s Retirement Preparedness Lags as Youth Eye Early Exit, Report Says
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通